Cargando…
Patients with Spinal Cord Injuries Favor Administration of Methylprednisolone
Methylprednisolone sodium succinate (MPSS) for treatment of acute spinal cord injury (SCI) has been associated with both benefits and adverse events. MPSS administration was the standard of care for acute SCI until recently when its use has become controversial. Patients with SCI have had little inp...
Autores principales: | Bowers, Christian A., Kundu, Bornali, Rosenbluth, Jeffrey, Hawryluk, Gregory W. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720442/ https://www.ncbi.nlm.nih.gov/pubmed/26789007 http://dx.doi.org/10.1371/journal.pone.0145991 |
Ejemplares similares
-
Methylprednisolone for acute spinal cord injury: an increasingly philosophical debate
por: Bowers, Christian A., et al.
Publicado: (2016) -
Efficacy and Safety of Methylprednisolone Sodium Succinate in Acute Spinal Cord Injury: A Systematic Review
por: Fehlings, Michael G., et al.
Publicado: (2017) -
Methylprednisolone Administration Following Spinal Cord Injury Reduces Aquaporin 4 Expression and Exacerbates Edema
por: Cabrera-Aldana, Eibar Ernesto, et al.
Publicado: (2017) -
Melatonin Synergizes With Methylprednisolone to Ameliorate Acute Spinal Cord Injury
por: Bi, Jiaqi, et al.
Publicado: (2022) -
Administration of High-Dose Methylprednisolone Worsens Bone Loss after Acute Spinal Cord Injury in Rats
por: Peng, Yuanzhen, et al.
Publicado: (2021)